Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 29.60
-0.25 (-0.84%)
Aug 17, 2026, 4:59 PM CET
Embla Medical Market Cap
Embla Medical has a market cap or net worth of 12.61 billion as of August 17, 2026. Its market cap has decreased by -3.88% in one year.
Market Cap
12.61B
Enterprise Value
15.49B
Revenue
6.44B
Ranking
n/a
PE Ratio
20.66
Stock Price
29.60
ChartMarket Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 2.33B to 12.61B, an increase of 441.86%. That is a compound annual growth rate of 10.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 12.61B | -9.23% |
| Dec 30, 2025 | 13.89B | -8.62% |
| Dec 30, 2024 | 15.20B | 31.74% |
| Dec 29, 2023 | 11.54B | -18.15% |
| Dec 30, 2022 | 14.10B | -21.07% |
| Dec 30, 2021 | 17.86B | -12.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.30T |
| Genmab | 121.01B |
| Coloplast | 96.44B |
| Demant | 62.72B |
| H. Lundbeck | 40.85B |
| Zealand Pharma | 22.27B |
| Ambu A/S | 20.20B |
| GN Store Nord | 14.89B |